TILRAY brands report a strong first quarter of financial results, emphasizing continuous growth with a record Q1 $ 210 million and net income
Operating efficiency and focus on the profitability of $ 1.5 million net income, adjusted EBITDA increased from 9% to $ 10 million, and $ 34 million annually improved.
Canadian adult Canadian Cannabis gross revenues increased by 12%, maintaining a position # 1 in the expansion of income and market share. International women’s income increased by 10%
Balance reinforced to $ 265 million in cash; Net debt has been reduced to $ 4 million
Repeats EBITDA Outlook adjusted for $ 2026 – $ 72 million
New York and London and London, Ontario, October 09, 2025 (Globe Newswire) – TILRAY Brands, Inc. (“Tilray”, “Our”, “We” or “Company”) (NASDAQ. TLRY; TSX.
His Evin D. Simon, President and Chief Executive Officer, as we enter 2026 financial, the results of the first quarter of “Tilra” outlines our shareholders of our strategic vision and disciplinary balance. Our global platform positions TILRAY brands will not only participate, but also to guide, global hemp, beverages and health effects. “
Mr. Simon continued. It is available to expand access, innovation and supports the world’s responsible regulatory progress. These achievements and nominated tendencies strengthen my unbreakable belief in the trajectory of the trail of Tilra and our ability to give our investors long-term value.
Financial needs: All comparisons made in the previous year
Net incomes increased by 5% in the first quarter to $ 209.5 million compared to 200.0 million.
Gross profit in the first quarter amounted to $ 57.5 million compared to $ 59.7 million.
Gross margin in the first quarter was 27% compared to 30%.
Cannabis Net revenues increased by 5% in the first quarter to $ 64.5 million, which is $ 61.2 million.
The gross gain of greens in the first quarter amounted to $ 23.3 million compared to $ 24.2 million.
The gross Cannabis margin in the first quarter was 36% compared to 40%.
The net income of the beverages in the first quarter amounted to $ 55.7 million compared to $ 56.0 million.
The gross profit in the first quarter amounted to $ 21.3 million compared to $ 22.9 million.
The gross margin in the first quarter was 38% compared to 41%.
Net health revenues increased to $ 15.2 million in the first quarter, compared to $ 14.8 million.
The gross health margin in the first quarter was 32% and unchanged.
The distribution net income in the first quarter amounted to $ 74.0 million compared to $ 68.1 million.
The distribution of gross margin in the first quarter was 11% compared to 12%.
Net income was $ 1.5 million in the first quarter, compared to the net loss of the dollar (34.7) million.
The regulated net income increased by $ 10.0 million in the first quarter to $ 3.9 million compared to $ (6.1) million.
Settled EBITDA increased by 9% in the first quarter to $ 10.2 million compared to $ 9.3 million.
Cash flow. The cash used in the operation has significantly improved by $ 34.0 million (1.3) million (35.3) million.
Balance update. In the first quarter, TILRAY reduced its outstanding debt for $ 7.7 million, further strengthening the balance. As a result, the net debt ratio related to the twelve months adjusted EBITDA was reduced to 0.07X. Our $ 264.8 million in cash is providing great tiltric flexibility for strategic opportunities.
Live audio web web
These results in the morning 8: 30 o’clock at 8 o’clock. On 30, web brands will be conducted to discuss these results. Investors can connect to the Department of Measures and Presentations of LIVEST Investors. Reproduction will be presented on the company’s website.
About TILRAY brands
TILRAY Brands, Inc. (Nasdaq: TLRY; TSX; TSX
For more information on how we raise life through communication moments, visit Tilray.com and follow all the social platforms of @ TILRAY.
NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number
You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
This morning (NASDAQ. OGI) (TSX. Ogi) announced expanding its efforts in the United States by importing a New brand of Hemp-received THC productsDistributed to market access to beverages that have recently been done. Gummy products for sale in 23 states, at first direct sales, and the company expands a retail wave until the end of 2025.
Of course, other Canadian LPs are located in a beverage like Begorigram, including the growth of the canopy (NASDAQ. CGC), TILRAY brands (NASDAQ. VFF). Cronos Group (NASDAQ. CRON) (TSX. CRON) market went out in 2023. None broke the effect of results or profits.
Most MSOS is not in the market yet and watch it as a competitive threat. However, the three largest income MSOS has entered the cannabis market. CURALEAF (OTC: Curlf) (TSX: Cura) converted to Florida Dispens of the Cannabis Product Store, Perception (CSE: GTIF) (CSE:
I am in favor of the cannabis regulated hemp industry integrating with the cannabis industry. In August 2023 I discussed of hemp as well as a threat of opportunity For the cannabis industry, and no lady was not yet involved. There is no longer a lot of adoption, but it’s nice to see Canadian LPS with their NASDAQ listings, access space. Perhaps one will provide a breakthrough of income.
Many states are pushing back against cannabis (like this week like Ohio), and can be a federal step to settle or ban them. I think that such cannabis products that are similar to the same regulator must be settled. Will finally try the FDA. States will be cannabis for their cannabis regulatory agencies. These are important issues that investors should follow carefully.
Frankly,
Alan
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
Exclusive
To get real-time updates follow Alan X.com:A number can also share and discover industry news along with sympathetic people, a large hemp group and entrepreneurship group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
The shares of Cannabis, as measured by the Cannabis Global Stock Index, were quite unstable in 2024 and were 2025. In December, the figure fell by 7.5%, reducing by 15.2% year by 15.2%, as well as a new time since 2025. In April, the figure increased by 11.5%, but it was completed below Q2, closing on 5.02. Q3 was strong in July-August, and September, which began retreated with another profit until the last day’s return. The index is over 0.8% down to a decline of 7.68.
After the collapse of 6.88% from Q4 to 6.88, the figure has decreased a lot in Q1, then, in terms of termination, Q2. The Cannabis Global Stock Index, which now has 23 members, has decreased by 27% a year in June. After 53.0% of Q3, the figure is currently growing by 11.6% a year.
Since the top of February of 2021, the Global Cannabis stock index has fallen from 92.48 from 92.48.
In September, the strongest 3 names increased by more than 10%.
Each of these shares is annually. Tlry picked up 317.5% during Q3, OGI reached 50.4% and Grwg Rose 100.0%
The three weakest names in September have fallen more than 17%.
Each of these shares is year by year. During Q3, the CGC collected 40.6% and the other two fell.
The index was rejected near 9/30, and it was based on data on 9/23. The figure for Q4 will have 28 names, up to 23, with two removal and seven additions. Leaving Index is an EEX and IMCC. Turning the index by CRESCO LABF (OTC: Curlf) Newlake Capital (OTC: NLCP), Terascend (OTC: VRNOF) and SHF HOLDINGS SHFS). The indicator had a sub-legged effect, which has the lowest MSO that can ever be at 13.0% Q3, but after four additions it will be 25%. The largest subsection is 39.3%, and Canadian LPS is 25%. Biotech, Canadian retail and tillers each make 3.6%.
In one month, we will again summarize the performance of the index. In April, we combined what two articles were released, and we refresh the other indicators that the newly established women’s companies continue to maintain the American Canadian Canadian index.
American Cannabis Operator Index:
In September, ACOI fell by 13.9% to 12.99. It increased in 123.6%, at 3:30 a year, from 551%, from 8.36.
The strongest fund in September was Jushi Holdings (OTC: Jushf), which decreased by 5.3%. The weakest, Terrace (OTC: TSNDF) (TSX: TSND), fell by 28.7%.
In October, the figure will have eight members with a planet’s removal of 13 (OTC. PLNH).
Auxiliary Cannabis Postcode:
In September, the assistance lost 5.3%, as the index rose fell from 13.43 to 12.72. The figure of 14.5% in Q3 has so far decreased by 7.6%.
In September, the strongest fund increased by 10.0%. The weakest, the capital of advanced flowers (NASDAQ. AFCG) decreased by 17.8%.
In October, the figure will have ten members with pledge and plans.
Canadian Cannabis LP index
In September, the Canadian LPS fell by 0.8%, as the figure fell from 74.16 to 73.56. Index collected at q3 78.4% and is now 46.8% in 2025, from 50.11.
In June, the strongest Canadian LP was TILRAY brands (TSX: TLRYE), which increased by 27.0%. Just soluble (TSXV. HASH) was the weakest, it was 26.7%.
In October, the figure will again have the same twelve members.
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
Every quarter, I refresh the Cannabis Stock Index, which covers active cannabis shares. The index returns at the end of 2012 and developed as the cannabis industry developed. I will share the full update next week, when Q3 is over, but I want to discuss a change in the index on the upcoming re-elexatization, which was based on data on 09/23.
The last quarter, I refreshed that the figure would again have 23 members, which is a typical type of shares. What surprised me about changes was that the MSOS in the index went down 6 to only 3. It is possible that the removal of its low trade in June may have been more shocking. 3 MSOS presented only 13% of the index at 6/30.
This next quarter, the number of shares, which qualifies 28, four new or returning members, are given to MSOS. Returning the indicator will be CRESCO LABS, CURALAF, TERRASCEND and VERANO HOLDINGS. On 7/30, on 7/30, 25% of the 7s index will be presented. Although MSOS’s share has sharply increased, this is not a high percentage. At the end of April 2024, only only only MSOS was 38% of the index when there were 11 MSOS 29.
I have constantly discussed how cannabels and investors can extend their concentration beyond only one part of the cannabis, so “only 25%” do not stand out to me. It’s the same percentage of what Canadian LPS is holding and it is inferior to 39% of assistance. MSOS has a great drawback because they trade on OTC, but they also face 280e taxation, which is combined with the debt of the balance sheet sheet.
The Rebalanced index will include all 5 of the largest MSOS, plus two people. The most interesting thing for me is what will not include. Of course, the heart is no longer in the figure, but there are several msos that are not yet in it, despite their mass income. The one who stands out is Vireo’s growth, which is not described due to its trading volume, which has not increased enough.
The growth of Varo first started trading in early 2019. For some time, it was an increase of kindness, but last summer became a virus. Originally, it was a medical canpian company based in Minnesota and operates in New York before I expanded Maryland. The company had to be united with the review, but the deal was distinguished and remained in court. Bengal Bengal Capital Josh Rosen joined as an interim executive director in early 2023 and became General Director in the summer of 2024 before leaving for October. The current CEO of the company, John Mazarakis, who joined Chicago Atlantic, at the end of 2024 as a company announced a big plan Buy 4 single state operators and collect $ 75 million for one share for $ 0.625. Company actually raised $ 81 millionA number of this was quite impressive.
There have been some people who are discussing Vireo growth, including multiple jacket Aaron Edelheit in many articles, as well as Pablo Zuanic. The company has already closed most of the achievements announced in December and caused $ 48 million, completing the quarter for $ 106 million in cash. Still, it seems that a lot of analyst does not seem coverage. In the past month, the shares on average made a daily trading shares that are lower than $ 400k minimum required.
Perhaps more disappointing than the lack of interest in investors has been the price of prices. At the end of 2024, the shares are currently kept by 10.7% when the company announced that it sold $ 81 million worth $ 0.625. MSOS gathered by 22%, and Cannabis Global Index has purchased 4.9% as of 9/25. Since the company announced transactions, it doubled at prices by 22% with MSOS. While the return of a year in MSOS is a lot, the vodge has been a little advanced.
Of course, Varo’s growth has seen a lot over the past few years. In 2023, it took the low level of all time, but the shares were falling since August. Cannabis investors should consider it. Big capital raising is underwater, and the volume of trade is small compared to the size of its actions.
Commercial volumes have expanded, especially for MSOS, and Varo’s growth has been transformed into itself. Investors, however, seem to be not yet. I continue to control the company’s evolution, but still do not include it in my focus of 19 shares. I want the growth of Viro to the best and hope that the buyers of his shares are approaching the end of the year, now 20%, do not stay in the red.
Frankly,
Alan
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
Exclusive
To get real-time updates follow Alan X.com:A number can also share and discover industry news along with sympathetic people, a large hemp group and entrepreneurship group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email